Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$299K Buy
2,061
+157
+8% +$21.7K 0.06% 123
2026
Q2
$245K Sell
1,904
-4
-0.2% -$468 0.05% 128
2026
Q1
$230K Buy
+1,908
New +$220K 0.06% 123
2024
Q4
– Sell
-2,302
Closed -$264K – 117
2024
Q3
$264K Buy
2,302
+290
+14% +$34.5K 0.09% 98
2024
Q2
$257K Sell
2,012
-49
-2% -$6.31K 0.09% 92
2024
Q1
$268K Buy
+2,061
New +$254K 0.1% 87

Other funds holding MRK

GSG Advisors's MRK Position: Q3 2026 in Review

GSG Advisors increased its Merck (MRK) stake by 8.2% in Q3 2026, buying an estimated $21.7K and bringing the position to 2,061 shares worth $299K. The position accounts for 0.06% of the portfolio, ranked #123.

GSG Advisors first reported a position in MRK in Q1 2024 and has held it in 6 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • GSG Advisors held 2,061 shares of Merck worth $299K as of Q3 2026.
  • GSG Advisors bought 157 Merck shares in Q3 2026, an estimated $21.7K.
  • Merck made up 0.06% of GSG Advisors's portfolio in Q3 2026, its #123 holding.
  • GSG Advisors first reported a position in Merck in Q1 2024 and has held it in 6 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on GSG Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.